"I love Imetelstat | Myelofibrosis | Myelodysplastic Syndrome | Geron"
www.geron.com VS www.gqak.com
2022-06-14 01:57:56
Imetelstat: a first-in-class telomerase inhibitorA unique molecule targeting a hallmark of cancerLearn More AboutOur Clinical TrialsRead moreTogether we can make a difference in patients’ livesPartneringis akeyto our successA visionary historyCreating a legacy of bold innovationAbout UsOverview History Management Board of Directors Partnering Our Culture Contact R & DTelomerase Imetelstat Publications PipelineR & D Pipeline For PatientsClinical Trials IMerge Phase 3 IMpactMF IMproveMF IMpress TELOMERE Hematologic Malignancies Expanded Access Policy CareersOpportunities InvestorsPress Releases Events Stock Information Corporate Governance SEC Filings Analyst Coverage FAQs Publications HomeAbout UsOverview History Management Board of Directors Partnering Our Culture Contact R & DTelomerase Imetelstat Publications PipelineR & D Pipeline For PatientsClinical Trials IMerge Phase 3 IMpactMF IMproveMF IMpress TELOMERE Hematologic Malignancies Expanded Access Policy CareersOpportunities InvestorsPress Releases Events Stock Information Corporate Governance SEC Filings Analyst Coverage FAQs Publications Terms of Use Privacy Policy Cookie Policy Copyright ©2022 GeronAll rights reservedTerms of Use Privacy Policy Cookie Policy Website Design: Hane Chow, Inc.
